Zhifeng Wang

Zhifeng Wang

Auto-generated profile, based on publicly available information

Zhifeng Wang

The First Clinical Medical College Yunnan University of Chinese Medicine Kunming China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2025 in The American Journal of Chinese Medicine
Verified
Journal Article
Closed access
YXYujiang Xi
Yujiang Xi
ZWZhifeng Wang
Zhifeng Wang
YWYuanyuan Wei
Yuanyuan Wei
NXNiqin Xiao
Niqin Xiao
LDLi Duan
Li Duan
DQDongdong Qin
Dongdong Qin

16 May 2026 in Journal of Central Nervous System Disease
Verified
Journal Article
Open access
DTDaman Tian
Daman Tian
JYJiao Yang
Jiao Yang
ZWZhifeng Wang
Zhifeng Wang
JLJunfeng Lan
Junfeng Lan
TSTing Shi
Ting Shi
LXLi Wei Xing
Li Wei Xing
Ischemic stroke (IS), a predominant cerebrovascular disorder contributing to global disability and mortality, characterizes by a complex, multi-tiered cascade of pathological processes. As the primary innate immune cells within the central nervous system (CNS), microglia exhibit dual functional characteristics following ischemic injury, switching dynamically between pro-inflammatory detrimental phenotypes and anti-inflammatory reparative phenotypes in response to temporal progression, cellular phenotypic transformation, and changes in the local microenvironment. Consequently, therapeutic strategies targeting microglia have garnered considerable research interest, challenging the traditional neuron-centric therapeutic approaches. Microglia display a wide range of phenotypes, and the traditional M1/M2 classification is overly simplistic, failing to capture the full spectrum of their functional diversity. In contrast, single-cell RNA sequencing (scRNA-seq) technology has surpassed the limitations of bulk sequencing, providing a robust tool for elucidating microglial heterogeneity. Recent studies utilizing animal models of stroke have identified several subsets distinct from the conventional M1/M2-like subsets, including but no limited to ischemic stroke-associated microglia (ISAM), Prdx1 + SAM, Spp1 + microglia and SAM-foamy. The mechanisms underlying microglial heterogeneity encompass innate programming influenced by genetic background, dynamic remodeling of epigenetic modifications, metabolic reprogramming in response to extrinsic microenvironmental stress, and intercellular interaction networks. This review systematically examines, from the perspective of scRNA-seq, the biological functions of MG, the heterogeneity observed throughout their CNS life cycle development and regional homeostasis, the characteristics and regulatory mechanisms of heterogeneous microglial subpopulations following ischemic stroke, and potential therapeutic strategies and associated challenges. The aim is to provide a reference for the development of precise therapeutic strategies for IS.

14 October 2026 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
ZWZhifeng Wang
Zhifeng Wang
TSTing Shi
Ting Shi
DTDaman Tian
Daman Tian
RLRui Li
Rui Li
TYTing Yao
Ting Yao
JWJian Wang
Jian Wang
Skin wound repair involves four stages: haemostasis, inflammation, proliferation and remodelling. Refractory wounds feature prolonged healing cycles, severe scar hyperplasia and limited clinical therapeutic strategies. Panax notoginseng saponins (PNS), primarily the ginsenosides Rg1 and Rb1 monomers, display high safety and multitarget regulatory properties across the entire wound repair cycle. PNS modulates the inflammatory microenvironment and induces M2‐type polarization of macrophages by inhibiting NF‐κB, MAPK and other signalling pathways; activates the PI3K/AKT pathway to promote the proliferation and migration of keratinocytes and fibroblasts, and maintains the physiological ratio of collagen type I/III; and upregulates angiogenic factors, including VEGF and bFGF, improving local blood circulation to enhance angiogenesis. Meanwhile, it regulates collagen metabolism, blocks the TGF‐β1/Smad2/3 scar‐related pathway, and counteracts oxidative stress, thereby accelerating wound healing while inhibiting scar formation. In recent years, PNS has shown promising potential in acute trauma, diabetic foot ulcers, burns and scar repair. PLGA/chitosan nanocarriers, hydrogels, electrospun fibrous membranes and smart responsive delivery systems have effectively addressed limitations of traditional dosage forms, including low bioavailability, poor skin permeability and uneven drug release. Nevertheless, research gaps remains: unclear targets of core monomers r; ambiguous pathway interactions among monomers; and poorly understood crosstalk between signalling pathways; studies on the impacts of extraction processes on pharmacodynamic effects are lacking; and high‐level clinical evidence is inadequate. Thus, PNS possesses substantial potential for treating refractory wounds because of its multi‐component synergy and full‐cycle regulation. Future research should focus on in‐depth exploration of molecular mechanisms, standardization of extraction processes, optimization of smart delivery systems and implementation of high‐quality clinical studies to promote the translation of active ingredients from traditional Chinese medicine into modern precision therapies.

17 April 2023 in F1000Research
Verified
Journal Article
Open access
PDF file
FYFei Yang
Fei Yang
ZZZhiYun Zhang
ZhiYun Zhang
WWWeiPing Wan
WeiPing Wan
ZWZhen Wang
Zhen Wang
LLLanQing Li
LanQing Li
JWJian Wang
Jian Wang
Background: Middle cerebral artery occlusion (MCAO) ischemia-reperfusion in rats is a commonly used in vivo model in stroke research, but the problems of long time-consuming, unstable neurological injury and high mortality are not conducive to an experimental animal study. In this study, the success rate of the MCAO model in rats was improved by changing the surgical approach and giving preoperative as well as postoperative care support. Methods: Place A-wire below the common carotid artery (CCA) to ligate the proximal end of the CCA, B-wire to fix the filament, and C-wire to pull the filament through the bifurcation of the internal carotid artery (ICA) and the external carotid artery (ECA). After temporarily clamping the ICA, insert the filament into the CCA incision, then drag the C-wire to reduce the angle between the CCA and the pterygoid artery (PPA) to avoid filament insertion into the PPA. Push forward the head of the filament to the middle cerebral artery (MCA), ventral thalamic artery (VTA), and anterior choroidal segment to block the blood supply. Neurological function scoring, triphenyltetrazolium chloride (TTC) staining and Nissl staining were applied to evaluate the model success or failure, the infarct area and neuro damage. Results: Compared with the traditional Zea longa mapping method, our method significantly reduced modeling time and surgical trauma and improved postoperative survival rate and success rate. Furthermore, our method is more consistent in terms of infarct area, and there was a significant reduction in Nissl bodies. Conclusions: The wire-lifting method pulls the vessel, reduces the angle between the CCA and the PPA, facilitates the insertion of the filament into the MCA to avoid the accidental insertion of the filament into the PPA, reduces the surgical trauma, and saves the model preparation time, which can effectively improve the survival rate and modeling success rate.

1 January 2026 in Stroke Research and Treatment
Verified
Journal Article
Open access
PDF file
JYJiao Yang
Jiao Yang
ZWZhifeng Wang
Zhifeng Wang
TSTing Shi
Ting Shi
SWShiyuan Wu
Shiyuan Wu
PHPengfen He
Pengfen He
JWJian Wang
Jian Wang
Cerebral ischemic stroke (CIS) is an acute cerebrovascular disease associated with high morbidity and disability rates. It is characterized by neurological damage caused by the interruption of cerebral blood flow, often accompanied by sequelae such as motor dysfunction and cognitive decline, which seriously affect the quality of life of patients. Despite continuous advancements in treatment methods, challenges persist, such as time window constraints, limited efficacy, and potential adverse reactions. Therefore, finding more proactive and effective treatment approaches has become an urgent problem to be solved. The mechanism of action of terpenoids is not a simple single‐target inhibition. Essentially, it lies in the systematic remodeling of the postischemic neural microenvironment. The pathophysiological process of CIS involves complex cascades, including energy failure, excitotoxicity, oxidative stress, neuroinflammation, disruption of the blood–brain barrier, multiple cell death pathways, mitochondrial dysfunction, and impairment of nerve repair. Terpenoids can intervene in ischemic stroke through a dual‐mechanism approach of direct neuroprotection and indirect microenvironment regulation by targeting key nodes within the abovementioned pathological network, ultimately achieving the protection and restoration of neural function. The aim of this review was to deepen the understanding of the therapeutic value of terpenoids in stroke; from an integrated perspective, it revealed the scientific essence of the multitarget synergistic effects of natural products, thereby providing a theoretical cornerstone and an innovative direction for the development of next‐generation drugs for treating stroke.